Home › Entities › clinical_trial › A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901

A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901

clinical trial
MedicalStudy clinical_trial Q98603723
Press Enter · cited answer in seconds

A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901

Summary

A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 is a clinical trial[1].

Key Facts

  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 is in the country of Taiwan[2].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's instance of is recorded as clinical trial[3].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's start time is recorded as +2020-09-01T00:00:00Z[4].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's end time is recorded as +2021-12-31T00:00:00Z[5].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's number of participants is recorded as {'unit': '1', 'amount': '+45'}[6].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's title is recorded as A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901[7].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+20'}[8].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's ClinicalTrials.gov ID is recorded as NCT04487210[9].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}[10].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's clinical trial phase is recorded as phase I clinical trial[11].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's research site is recorded as National Taiwan University Hospital[12].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's research subject recruitment status is recorded as not yet recruiting[13].
  • A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901's study type is recorded as interventional study[14].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901. Retrieved May 3, 2026, from https://4ort.xyz/entity/a-phase-i-prospective-open-labeled-study-to-evaluate-the-safety-and-immunogenicity-of-mvc-cov1901
MLA “A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/a-phase-i-prospective-open-labeled-study-to-evaluate-the-safety-and-immunogenicity-of-mvc-cov1901.
BibTeX @misc{4ortxyz_a-phase-i-prospective-open-labeled-study-to-evaluate-the-safety-and-immunogenicity-of-mvc-cov1901_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901}}, year = {2026}, url = {https://4ort.xyz/entity/a-phase-i-prospective-open-labeled-study-to-evaluate-the-safety-and-immunogenicity-of-mvc-cov1901}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 — https://4ort.xyz/entity/a-phase-i-prospective-open-labeled-study-to-evaluate-the-safety-and-immunogenicity-of-mvc-cov1901 (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/a-phase-i-prospective-open-labeled-study-to-evaluate-the-safety-and-immunogenicity-of-mvc-cov1901 · Last refreshed: